High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy

AIDS. 2022 Nov 1;36(13):1881-1882. doi: 10.1097/QAD.0000000000003326.
No abstract available

MeSH terms

  • Drug Resistance, Viral
  • HIV Infections* / drug therapy
  • HIV Integrase Inhibitors* / pharmacology
  • HIV Integrase Inhibitors* / therapeutic use
  • Heterocyclic Compounds, 3-Ring / pharmacology
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Oxazines
  • Piperazines
  • Pyridones / therapeutic use
  • Recombination, Genetic
  • Salvage Therapy

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir